CQUniversity
Browse

Determinants of antiretroviral therapy initiation and treatment outcomes for people living with HIV in Vietnam

journal contribution
posted on 2018-09-19, 00:00 authored by D Tran, A Shakeshaft, A Ngo, KA Mallitt, D Wilson, Christopher DoranChristopher Doran, L Zhang
Objectives: This study explores patient characteristics that are significantly associated with very late combination antiretroviral therapy (cART) initiation (CD4 count â‰100 cells/mm < sup > 3 < / sup > ) and examines the association between patient characteristics and treatment outcomes, CD4 recovery, and mortality. Design: Data were obtained from the clinical records of 2,198 HIV/AIDS patients in 13 outpatient clinics across 6 provinces in Vietnam. Methods: Multivariate logistic regression and Cox proportional hazards regression were used to identify patient characteristics that are significantly associated with very late cART initiation and to measure relationships between patient characteristics and treatment outcomes. Results: Very late cART initiation was significantly associated with being male compared with female (odds ratio [OR], 0.36; 95% CI, 0.23-0.58), becoming HIV infected through injecting drugs (OR, 2.13; 95% CI, 1.09-4.14), and having opportunistic infections at cART initiation (OR, 1.69; 95% CI, 1.02-2.86). Being male (female vs male: hazard ratio [HR] , 0.45; 95% CI, 0.20-0.98), very late cART initiation (timely vs late: HR, 0.18; 95% CI, 0.04-0.72), low baseline body mass index (BMI) (HR, 0.95; 95% CI, 0.92-0.98), and later baseline WHO clinical stage (WHO clinical stage IV vs combined group of stage I and II: HR, 5.70; 95% CI, 3.90-7.80) were significantly associated with death, whereas being female compared with male (HR, 1.51; 95% CI, 1.14-1.99) and timely cART initiation (HR, 35.45; 95% CI, 13.67-91.91) were significant predictors of CD4 recovery. Conclusions: Timely testing of patients for HIV, increasing use of CD4 count testing services, and starting cART earlier are essential to reduce mortality and improve treatment outcomes. © 2013 Thomas Land Publishers, Inc.

History

Volume

14

Issue

1

Start Page

21

End Page

33

Number of Pages

13

eISSN

1945-5771

ISSN

1528-4336

Publisher

Taylor & Francis

Peer Reviewed

  • Yes

Open Access

  • No

External Author Affiliations

National Drug Alcohol Research Centre; University of New South Wales; University of South Australia; University of Newcastle, Hunter Medical Research Institute

Era Eligible

  • Yes

Journal

HIV Clinical Trials

Usage metrics

    CQUniversity

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC